2-es típusú cukorbetegség: vizsgálatok itt: Kína
193 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisNot yet taking people in KínacfMSC Therapy for Diabetes
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT07495956 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Chenzhou, Chifeng, Hangzhou, Hefei, Huai'an, Jinan, Jincheng, Jining, Jinzhou Shi, Kaifeng, Langfang, Liangyugang, Luoyang, Meihekou, Nanjing, Nantong, Nanyang, Pinggu, Pingxiang, Sanya, Shanghai, Shantou, Shenyang, Shijiazhuang, Tianjin, Wuhan, Wuhu, Xi'an, Xiangyang, Xianyang, Xuzhou, Yan’an, Yueyang, Zhumadian, Zibo
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - 3. fázisNot yet taking people in KínaA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Beijing, Cangzhou, Changchun, Changsha, Chengdu, Danyang, Ganzhou, Guiyang, Hengshui, Huizhou, Lanzhou, Panjin, Qiqihar, Shanghai, Suzhou, Xiamen, Xianyang, Zigong
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - No phaseTaking peopleAcupuncture Plus Mecobalamin for Diabetic Cardiac Autonomic Neuropathy
- Where
- Nanjing
- Életkor
- 18 év to 70 év
- People
- 60
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07907536 - 3. fázisNot yet taking people in KínaA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Beijing, Cangzhou, Changchun, Chengdu, Danyang, Ganzhou, Guangzhou, Huizhou, Huzhou, Lanzhou, Nanjing, Panjin, Suzhou, Xianyang
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - 4. fázisTaking peopleA Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China
- Where
- Anyang, Baotou, Beijing, Changchun, Changzhou, Chengdu, Dalian, Fuyang, Huizhou, Jinan, Lanzhou, Linhai, Nanjing, Ningbo, Panjin, Pingxiang, Shanghai, Shantou, Shijiazhuang, Siping, Xining, Yibin, Yichang, Zhenjiang
- Életkor
- 18 év and over
- People
- 300
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07900438 - No phaseTaking peopleAI-Driven Metabolic Cohort in Overweight/Obese Chinese Adults
- Where
- Guangzhou
- Életkor
- 18 év to 60 év
- People
- 2800
- Run by
- Zhujiang Hospital
See details and how to joinNCT07584330 - 3. fázisTaking peopleA Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Where
- Changsha, Hefei, Huai'an, Langfang, Liangyugang, Luoyang, Nanjing, Nanyang, Pinggu, Pingxiang, Shijiazhuang, Tianjin, Yueyang
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00 - No phaseNot yet taking people in KínaImpact of AI-Based Breath Ammonia Kidney Function Results on Clinical Pharmacist Medication Recommendations
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 380
- Run by
- Shanghai Pudong Hospital
See details and how to joinNCT07888855 - No phaseNot yet taking people in KínaChinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks
- Where
- Taiyuan
- Életkor
- 18 év to 79 év
- People
- 25 974
- Run by
- Shanxi Bethune Hospital
See details and how to joinNCT07884903 - No phaseNot yet taking people in KínaPreventive Effectiveness of Primary Care Physician-led CGM-supported Comprehensive Intervention on Cardio-metabolic-immune Diseases in Community Patients With Type 2 Diabetes (Community Diabetes Control Project)
- Where
- Changsha
- Életkor
- 18 év to 80 év
- People
- 15 400
- Run by
- Xiangya Hospital of Central South University
See details and how to joinNCT07885904 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Binzhou, Chengdu, Deyang, Ganzhou, Guangzhou, Haikou, Hangzhou, Huaian, Huzhou, Jinan, Jinzhou, Kunming, Lanzhou, Linhai, Liuzhou, Luoyang, Nanchang, Nanjing, Nantong, Ningbo, Panjin, Pingxiang, Qingdao, Shanghai, Shenyang, Shenzhen, Siping, Suining, Suzhou, Ürümqi, Wanzhou, Wenzhou, Wuhan, Wuxi, Xiangyang, Xuancheng, Yibin, Yichang, Zhengzhou, Zhenjiang, Zunyi
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 3. fázisTaking peopleA Study of BGM0504 in Early T2DM With Obesity
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 372
- Run by
- BrightGene Bio-Medical Technology Co., Ltd.
See details and how to joinNCT07743983 - 2. fázisNot yet taking people in KínaA Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 120
- Run by
- Vincentage Pharma Co., Ltd
See details and how to joinNCT07872436 - Korai 1. fázisTaking peopleEfficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 84
- Run by
- Tongji Hospital
See details and how to joinNCT06964620 - 2. fázisNot yet taking people in KínaA Study of HRS-4729 Injection in Participants With Type 2 Diabetes
- Where
- Tianjin, Wuhan
- Életkor
- 18 év to 65 év
- People
- 240
- Run by
- Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07843862 - 1. fázisNot yet taking people in KínaA Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple Doses
- Where
- Jinan
- Életkor
- 18 év to 55 év
- People
- 122
- Run by
- Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07841860 - No phaseTaking peopleA Clinical Study on Using Multimodal Ultrasound to Assess Muscle Mass in Metabolic Diseases
- Where
- Zhangzhou
- Életkor
- 18 év and over
- People
- 320
- Run by
- Zhangzhou Municipal Hospital
See details and how to joinNCT07836088 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Beijing, Chengdu, Guangzhou, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing, Shanghai
- Életkor
- 18 év and over
- People
- 1980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - No phaseNot yet taking people in KínaA Multicenter Randomized Double-Blind Trial of Chrocare CDSS for Integrated Management of Type 2 Diabetes
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 1200
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07833228 - No phaseTaking peopleIncidence and Clinical Features of Breakthrough Pain After Brachial Plexus Block in Diabetic Patients
- Where
- Taiyuan
- Életkor
- 18 év to 80 év
- People
- 216
- Run by
- Second Hospital of Shanxi Medical University
See details and how to joinNCT07833930 - No phaseTaking peopleThe Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive Impairment
- Where
- Nanjing
- Életkor
- 45 év to 80 év
- People
- 40
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07650318 - No phaseTaking peopleHuman Genes and Microbiota in Early Life
- Where
- Guangzhou
- People
- 20 000
- Run by
- Guangzhou Women and Children's Medical Center
See details and how to joinNCT06926166 - 1. fázisTaking peopleA Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment
- Where
- Chengdu
- Életkor
- 18 év to 65 év
- People
- 32
- Run by
- Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07807059 - No phaseCsak meghívásosResearch Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec
- Where
- Beijing, Chongqing, Harbin, Huai'an, Jiangmen, Jinan, Langfang, Lanzhou, Nanchang, Nanjing, Shanghai, Shenyang, Shiyan, Suzhou, Urumuqi
- Életkor
- 18 év and over
- People
- 216
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07658417